GLP-1 Providers in Connecticut (2026)

351 of the 444 sellers that publish a state list include Connecticut, the 27th-most of the 50 states and DC. 226 of them ship to all 50 states, and 1 serves 15 states or fewer. Across the 242 with a regular monthly price, the middle figure is $170/mo.

Connecticut Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Sellers and prices are broken out by drug on the semaglutide in Connecticut and tirzepatide in Connecticut pages.

Who Ships GLP-1s to Connecticut

1. WellMedRx $49/mo
2. Collective $59/mo
3. RxPepsDirect $64/mo

Lowest regular prices for Connecticut: WellMedRx at $49/mo, Collective at $59/mo and RxPepsDirect at $64/mo.

Smaller-footprint sellers that include Connecticut: Invite Wellness (14 states).

6 sellers that list 30 or more states leave Connecticut off, among them OurView Health, Trellis Vitality, Brello Health, Welm Health and Nimbus Healthcare.

Seller counts next door: Massachusetts 343, New York 369 and Rhode Island 328.

Browse by medication

Connecticut Medicaid and GLP-1 Coverage

Connecticut Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

• Wegovy to cut heart attack and stroke risk: covered with prior authorization (age of at least 18; no type 1 or type 2 diabetes and no NYHA class IV heart failure; A1c under 6.5%; BMI of at least 27; prior heart attack, prior ischemic or hemorrhagic stroke, or symptomatic peripheral artery disease; lifestyle program; renewal: at least 5% weight loss from baseline).
• Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2-F3).
• Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a BMI of at least 30; a CPAP trial first).

In 2025, Connecticut Medicaid paid for at least 174,430 GLP-1 prescriptions, including at least 101,853 for Ozempic, at least 2,125 for Wegovy, 50,327 for Mounjaro and at least 3,350 for Zepbound, about $202.7 million before manufacturer rebates. Drugs labeled for weight loss made up 3% of that spending.

Medicaid rules checked November 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Connecticut

Connecticut has 442 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 12.03 per 100,000 residents (4th of 51). By specialty: 172 bariatric, 272 endocrinology and 5 obesity medicine. About 32% of adults here had obesity in 2024 (CDC), the 36th-highest rate of the 50 states and DC. Measured against the median state, Connecticut has 0.66 times as much adult obesity per specialist practice.

Largest Cities in Connecticut

Frequently Asked Questions